{"database": "openregs", "table": "documents", "rows": [["FDA-2021-N-0862-0009", "FDA", "FDA-2021-N-0862", "Reference 7- FDA Preliminary Regulatory Impact Analysis_Initial Regulatory Flexibility Analysis Unfunded Mandates Reform Act Analysis  re: Nonprescription Drug Product With an Additional Condition for Nonprescription Use", "Supporting & Related Material", "Background Material", "2022-06-28T04:00:00Z", 2022, 6, null, null, "2022-06-28T13:43:52Z", null, 0, 0, "09000064851a6e04"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2021-N-0862-0009"], "units": {}, "query_ms": 136.57796708866954, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}